Wassef R, Cohen Z, Langer B
Transplantation. 1985 Nov;40(5):489-93. doi: 10.1097/00007890-198511000-00004.
This study was performed to determine the influence of different routes of administration and of variable doses of cyclosporine (CsA) on the pharmacokinetics of CsA in the rat. Seven groups of 4 adult female Lewis rats were given CsA once daily for 5 days: group 1: 5 mg/kg of CsA p.o. (by gavage); group 2: 10 mg/kg of CsA p.o.; Group 3: 5 mg/kg of CsA i.m.; group 4: 10 mg/kg of CsA i.m.; Group 5: 5 mg/kg of CsA s.c.; group 6: 10 mg/kg of CsA s.c., group 7: 10 mg/kg CsA i.p. CsA plasma levels were determined by RIA at 0, 2, 4, 6, 8, and 24 hr on days 1 and 4. Ease of administration was greatest in the s.c. groups (3 and 4), in which no anesthesia, no restraining device, and no special skills were required. Peak CsA levels varied greatly from group to group, as did trough levels and CsA bioavailability, as determined by the total area under the plasma CsA concentration-time curve. All groups exhibited great variation of CsA plasma level in the 24-hr period following administration, except group 3, in which the peak-to-trough difference was only 26.8% of peak level, as opposed to values over 60% in all other groups. We conclude that: (1) CsA may be administered to rats through different routes to achieve adequate plasma levels; (2) the route and dosage will greatly influence the pharmacokinetic profile of CsA; and (3) the SC route, in addition to being the easiest, provides reproducible and steady CsA plasma levels, with little variation over a 24-hr period.
本研究旨在确定不同给药途径和不同剂量的环孢素(CsA)对大鼠体内CsA药代动力学的影响。将七组,每组4只成年雌性Lewis大鼠,每天给药一次CsA,持续5天:第1组:口服(灌胃)5mg/kg CsA;第2组:口服10mg/kg CsA;第3组:肌肉注射5mg/kg CsA;第4组:肌肉注射10mg/kg CsA;第5组:皮下注射5mg/kg CsA;第6组:皮下注射10mg/kg CsA;第7组:腹腔注射10mg/kg CsA。在第1天和第4天的0、2、4、6、8和24小时,通过放射免疫分析法(RIA)测定CsA血浆水平。皮下注射组(第3组和第4组)给药最简便,无需麻醉、约束装置和特殊技能。CsA的峰值水平在各组之间差异很大,谷值水平和CsA生物利用度也是如此,生物利用度由血浆CsA浓度-时间曲线下的总面积确定。除第3组外,所有组在给药后的24小时内CsA血浆水平均有很大变化,第3组的峰谷差值仅为峰值水平的26.8%,而其他所有组的值均超过60%。我们得出以下结论:(1)CsA可通过不同途径给药于大鼠以达到足够的血浆水平;(2)给药途径和剂量将极大地影响CsA的药代动力学特征;(3)皮下注射途径除了最简便外,还能提供可重复且稳定的CsA血浆水平,在24小时内变化很小。